Established in 1986 by the Jains, Mehtas and Munjals,
Ind-Swift is a leading pharmaceutical manufacturing and marketing company in India, based in Chandigarh.
Its strength lies in innovative pharmaceutical products. Ind-Swift has been ranked 35th in the Indian pharma industry and is the second
largest among the drug manufacturers in India (north India). It has spread its network across 45 countries. It is an ISO 9001-2008,
WHO GMP certified company. It is also listed on the Bombay Stock Exchange and National Stock Exchange.
It has 5 plants in India which include multi-purpose, multi-location facilities spread across northern India.

The facilities are built according to the current guidelines of MHRA, EU, WHO and accreditations with ISO 14000 series standards. The company has world class expertise in finished goods dosage, Active Pharmaceutical Ingredients (API’s) and herbal products. A talented team of research scientists, formulation experts, clinical development and regulatory affairs professionals support the company's marketing efforts not only across the country but also around the globe. Ind-Swift pharmaceutical products are safe, effective and have consistent quality.

The Nova Division being a multispecialty division, its portfolio covers all the therapeutic segments which are available in all the other divisions like respiratory inclusive of ENT, chest (anti- tuberculosis), dentistry, anti-infective, cardio-diabetic and orthopaedic therapies. After being tested and certified for quality, these medicines are packed in appropriate packing material. The range of medicines produced by the Nova Division is recognized for its effectiveness, long-shelf life and exact compositions catering to the ever increasing demand. This division produces a wide range of products, amongst which the most popular and the best selling are: Netazox, Majik, PhenaP, Truclar.

The Ethical division is dedicated to Gynaecology, Paediatrics, Dermatology and GP and its ambit extends to a wide range of medicines. These drugs are formulated conforming to national and international pharmaceutical standards and are 100% safe and highly effective. The aim of this division is to provide patients and physicians with new and improved medicines that have better efficacy and fewer side effects. The products are based on innovative technology that delivers tested and proven substances in a new way.
This division produces a wide range of gynaecology and dermatology products, amongst which the most popular and the best selling are: Suprox SR, Voranin, Malswift-D, Qlite Gel, Clarie.

Helping those who cannot afford costly branded medicines has always been on the Ind-Swift agenda and the Generics division provides the same active ingredients as their branded equivalents. The Generics division is further divided into Agile, Maxcare and Health Care divisions. The portfolio of these divisions includes an assortment of over 500 products from various therapeutic segments namely Antibiotic, Anti-Infectives, Anti-Cold, Nutraceuticals, Anti-Convulsants, Analgesics, Anti-Diarrhoeal, Anti-Allergics, Anti-Inflammatory and Anti-Ulcer Drugs, Hypolipidaemic Drugs, Anti Malarial, Enzyme, Expectorants, Antipsychotics & Anti-Depressants. The drugs are used for the treatment of a variety of common ailments such as fever, cough, cold, diarrhoea, body ache and infections and are available at reasonable prices.

Ind-Swift is a prominent organization and very well known amongst lakhs of employees of the railways, police force, armed forces and paramilitary organizations. The Institutional division of Ind-Swift caters to the government dispensaries (from the smallest to the biggest), hospitals even in the remote and rural areas of India.
The Institutional division of Ind-Swift caters to almost all the major government, semi-government and public sector undertakings in India. It is through this division that Ind-Swift makes its medicines available to even the remotest areas and army forward posts in Jammu and Kashmir and in the North- east. This division of Ind-Swift makes possible the government’s objectives of making the best quality medicines available to the common man at affordable prices. Ind-Swift’s adept team makes dedicated and untiring efforts in this direction to make these medicines available in almost every hospital in every corner of India.

Today Ind-Swift is at a reigning pedestal and it enjoys a dominant position in various therapeutic segments. Ind-Swift believes that quality healthcare services have no boundaries and thus it plan to spread its wings by diversifying into the Herbal and Nutraceutical and OTC divisions. The objective is to create a good balance in all therapeutic areas.

Nutraceutical Division :
The carefree and indulgent lifestyle that most of us follow today, leads to many lifestyle diseases like obesity, diabetes, cardiac and neurological disorders. Thus it is important to maintain a proper lifestyle with healthy options. The Nutraceutical division, which is in the pipeline, will manufacture products that offer healthy options and are in sync with today’s lifestyle. These products will not compromise on taste and convenience but at the same time will make your life more wholesome and functional. This division will produce healthy, nutritious and reliable health foods.
OTC Division :
It is Ind-Swift’s persistent endeavour to introduce new products and expand the already existing product range and thereby increasing the market share of its products. Ind-Swift is also venturing into the OTC market by opening its own division.